Hepatitis B virus treatment: Which patients should be treated with nucleos(t)ide analogue?
Mauro Viganò, Pietro Lampertico – 1 March 2013 – Watch a video presentation of this article
β1 integrin is a long‐sought sensor for tauroursodeoxycholic acid
Ulrich Beuers – 1 March 2013
Hepatitis B virus infection in children
Maureen M. Jonas – 1 March 2013 – Watch a video presentation of this article
Hepatitis B virus infection in children
Maureen M. Jonas – 1 March 2013 – Watch a video presentation of this article
Hepatitis B virus treatment: Which patients require immediate treatment
Robert P. Perrillo – 1 March 2013 – Watch a video presentation of this article
HBV treatment in a patient who will be receiving immunosuppressive therapy
Jordan J. Feld – 1 March 2013 – Watch a video presentation of this article
Hepatopathology of hepatitis B
Zachary D. Goodman – 1 March 2013 – Watch a video presentation of this article
Hepatopathology of hepatitis B
Zachary D. Goodman – 1 March 2013 – Watch a video presentation of this article
Viral hepatitis B coinfection with human immunodeficiency virus, hepatitis D virus, or hepatitis C virus
Tuyet A. T. Nguyen, Richard K. Sterling – 1 March 2013 – Watch a video presentation of this article
Left hepatectomy versus right hepatectomy for living donor liver transplantation: Shifting the risk from the donor to the recipient
Garrett R. Roll, Justin R. Parekh, William F. Parker, Mark Siegler, Elizabeth A. Pomfret, Nancy L. Ascher, John Paul Roberts – 27 February 2013 – Living donor liver transplantation (LDLT), originally used in children with left lateral segment grafts, has been expanded to adults who require larger grafts to support liver function. Most adult LDLT procedures have been performed with right lobe grafts, and this means a significant risk of morbidity for the donors. To minimize the donor risk for adults, there is renewed interest in smaller left lobe grafts.